Not CRISPR data: the image illustrates antibody quality for visualizing CRISPR experiment results.
Not CRISPR data: the image illustrates antibody quality for visualizing CRISPR experiment results.
Mnk2 CRISPR Activation Plasmid (h): sc-401879-ACT
- Target species: human
- 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
- Mnk2 CRISPR Activation Plasmid (h) is a synergistic activation mediator (SAM) transcription activation system designed to specifically upregulate gene expression
- Mnk2 CRISPR Activation Plasmid (h) consists of three plasmids at a 1:1:1 mass ratio: a plasmid encoding the deactivated Cas9 (dCas9) nuclease (D10A and N863A) fused to the transactivation domain VP64, and a blasticidin resistance gene; a plasmid encoding the MS2-p65-HSF1 fusion protein, and a hygromycin resistance gene; a plasmid encoding a target-specific 20 nt guide RNA fused to two MS2 RNA aptamers, and a puromycin resistance gene
- The resulting SAM complex binds to a site-specific region approximately 200-250 nt upstream of the transcriptional start site and provides robust recruitment of transcription factors for highly efficient gene activation
- gRNAs encoded by Mnk2 CRISPR Activation Plasmid (h) and Mnk2 CRISPR Activation Plasmid (h2) target distinct regulatory regions upstream of the MKNK2 transcriptional start site. One or both designs may be available
- Following transfection, gene knockout efficiency can be assayed by WB, IF or IHC using antibody: Mnk2 Antibody (B-6): sc-271559
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Mnk2 CRISPR Activation Plasmid (h) | sc-401879-ACT | 20 µg | $397.00 |
Human MKNK2 encodes MAP kinase–interacting serine/threonine-protein kinase 2 (Mnk2), a downstream effector of ERK and p38 MAPK signaling that modulates translation initiation by phosphorylating eIF4E and related substrates. Through coupling extracellular cues to cap-dependent mRNA translation, Mnk2 influences gene expression programs controlling cell growth, stress responses, and differentiation. Dysregulated MAPK–Mnk–eIF4E signaling has been associated with altered translational control in cancer biology, inflammation, and neurobiology, making MKNK2 a useful node for studying stimulus-dependent protein synthesis. Isoform-specific regulation and subcellular localization of Mnk2 further support investigation of context-dependent signaling and translational rewiring.
Mnk2 CRISPR Activation Plasmid (h) provides a targeted, non-destructive approach to upregulating endogenous MKNK2 expression without altering the underlying DNA sequence.
Mnk2 CRISPR Activation Plasmid (h) is a three-plasmid synergistic activation mediator (SAM) system engineered for highly efficient, site-specific transcriptional upregulation of the MKNK2 locus in human cell lines. The system is built around a catalytically inactive Cas9 (dCas9) carrying two inactivating mutations (D10A and N863A) that eliminate nuclease activity while preserving DNA binding. This dCas9 is fused to VP64, a potent transcriptional activator, and is co-expressed with a blasticidin resistance gene for selection. The second plasmid encodes the MS2-p65-HSF1 fusion protein, a secondary activator complex that works in concert with dCas9-VP64, alongside a hygromycin resistance gene. The third plasmid encodes a target-specific 20 nt sgRNA fused to two MS2 RNA aptamers that recruit the MS2-p65-HSF1 complex to the activation site, accompanied by a puromycin resistance gene. The three plasmids are delivered at a 1:1:1 mass ratio for balanced expression of all system components.
Once assembled at the target locus, the SAM complex binds within approximately 200 bp upstream of the MKNK2 transcriptional start site, where VP64, p65, and HSF1 act in concert to recruit transcriptional machinery and drive upregulation of endogenous Mnk2 expression. Unlike nuclease-active Cas9, dCas9 does not introduce double-strand breaks or modify the genomic sequence, preserving the native MKNK2 locus and enabling the study of Mnk2-dependent transcriptional responses at the endogenous locus, making it a valuable tool for functional studies, target gene identification, and the modeling of Mnk2 pathway restoration in tumor cells with silenced or reduced MKNK2 expression.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.